\-\ Texto\\:\\ \ \(0\)\
\-\ neurologic\\ exam\\:\ \(0\)\
\-\ mental\\ status\\:\\ alert\\ and\\ oriented\\ to\\ person\\,\\ place\\,\\ time\\.\\ \\ \ \(0\)\
\-\ cranial\\ nerves\\:\\ \ \(0\)\
\-\ ii\\:\\ vfftc\\,\\ perrl\\,\\ os\\:\\ indistinct\\ disc\\ margins\\ od\\:\\ indistinct\\ disc\\ margins\ \(0\)\
\-\ iii\\,iv\\,vi\\:\\ eomi\\,\\ smooth\\ pursuits\\,\\ hypometric\\ horizontal\\ and\\ vertical\\ saccades\\.\\ no\\ primary\\ or\\ gaze\\-evoked\\ nystagmus\\.\ \(0\)\
\-\ v\\:\\ momi\\,\\ sensation\\ intact\\ lt\\/pp\\ v1\\/v2\\/v3\\.\ \(0\)\
\-\ vii\\:\\ symmetric\\ muscles\\ of\\ facial\\ expression\\ in\\ upper\\/lower\ \(0\)\
\-\ viii\\:\\ hearing\\ intact\\ to\\ conversation\\.\\ \\ \ \(0\)\
\-\ ix\\,x\\:\\ symmetric\\ volitional\\ palate\\/uvula\\ rise\\,\\ no\\ hypophonia\\,\\ dysphonia\\,\\ no\\ dysarthria\\,\\ no\\ hoarseness\\.\\ \ \(0\)\
\-\ xi\\:\\ 5\\/5\\ scm\\ and\\ trapezius\\ strength\ \(0\)\
\-\ xii\\:\\ tongue\\ midline\\ on\\ protrusion\\,\\ no\\ fasciculations\\ or\\ atrophy\\.\ \(0\)\
\-\ motor\\:\\ normal\\ bulk\\ and\\ tone\\.\\ no\\ fasciculations\\,\\ mild\\ tremor\\ in\\ hands\\ l\\>r\\.\\ no\\ pronator\\ drift\\.\ \(0\)\
\-\ rue\\:\\ 5\\/5\\ deltoid\\,\\ biceps\\,\\ triceps\\,\\ wrist\\ flexion\\,\\ wrist\\ extension\\,\\ finger\\ flexion\\,\\ interossei\\ \ \(0\)\
\-\ lue\\:\\ 5\\/5\\ deltoid\\,\\ biceps\\,\\ triceps\\,\\ wrist\\ flexion\\,\\ wrist\\ extension\\,\\ finger\\ flexion\\,\\ interossei\\ \ \(0\)\
\-\ rle\\:\\ 3\\/5\\ hip\\ flexion\\,\\ hip\\ ab\\/adduction\\,\\ knee\\ flexion\\/extension\\,\\ 3\\/5\\ dorsiflexion\\,\\ 4\\/5\\ plantarflexion\ \(0\)\
\-\ lle\\:\\ 2\\/5\\ hip\\ flexion\\,\\ hip\\ ab\\/adduction\\,\\ knee\\ extension\\,\\ 3\\/5\\ knee\\ flexion\\,\\ dorsiflexion\\,\\ plantarflexion\ \(0\)\
\-\ sensory\\:\\ intact\\ and\\ symmetric\\ to\\ light\\ touch\\,\\ temperature\\,\\ and\\ vibration\\ in\\ the\\ upper\\ extremities\\.\\ \\ decreased\\ light\\ touch\\,\\ temperature\\ l\\>r\\ bilateral\\ feet\\ and\\ medial\\ legs\\.\\ mildly\\ decreased\\ vibratory\\ sensation\\ bilateral\\ lower\\ extremities\\.\\ \\ \\ \ \(0\)\
\-\ reflexes\\:\ \(1\)\
\-\ right\\:\\ biceps\\ 1\\/4\\,\\ triceps\\ 1\\/4\\,\\ br\\ 1\\/4\\,\\ patellar\\ 0\\/4\\,\\ achilles\\ 0\\/4\\,\\ plantar\\ up\ \(0\)\
\-\ left\\:\\ biceps\\ 2\\/4\\,\\ triceps\\ 2\\/4\\,\\ br\\ 2\\/4\\,\\ patellar\\ 0\\/4\\,\\ achilles\\ 0\\/4\\,\\ plantar\\ up\ \(0\)\
\-\ coordination\\:\\ finger\\-nose\\-finger\\,\\ finger\\ tapping\\ within\\ normal\\ limits\\ with\\ mild\\ end\\-point\\ tremor\\.\\ heel\\-shin\\ normal\\.\ \(0\)\
\-\ gait\\:\\ deferred\\ due\\ to\\ weakness\ \(0\)\
\-\ labs\\ unremarkable\ \(4\)\
\-\ infliximab\\ induction\\ therapy\\ and\\ maintenance\ \(0\)\
\-\ mri\\ of\\ the\\ lumbar\\ spine\\ with\\ and\\ without\\ contrast\\:\\ \ \(0\)\
\-\ comparison\\:\\ mri\\ lumbar\\ spine\\ dated\\ 5\\/14\\/2015\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ findings\\:\\ there\\ are\\ 5\\ non\\-rib\\ bearing\\ lumbar\\ type\\ vertebral\\ bodies\\.\\ \\ the\\ \ \(0\)\
\-\ vertebral\\ body\\ heights\\ and\\ alignment\\ are\\ maintained\\.\\ disc\\ desiccation\\ is\\ noted\\ \ \(0\)\
\-\ from\\ l2\\ to\\ s1\\,\\ with\\ partial\\ disc\\ height\\ loss\\ at\\ l5\\-s1\\.\\ fatty\\ degenerative\\ \ \(0\)\
\-\ endplate\\ changes\\ are\\ again\\ seen\\ at\\ l5\\-s1\\.\\ the\\ bone\\ marrow\\ signal\\ is\\ otherwise\\ \ \(0\)\
\-\ normal\\.\\ no\\ significant\\ spinal\\ canal\\ or\\ neural\\ foraminal\\ narrowing\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ the\\ conus\\ medullaris\\ terminates\\ in\\ a\\ normal\\ location\\ at\\ the\\ level\\ of\\ l2\\.\\ there\\ \ \(0\)\
\-\ is\\ increased\\ enhancement\\ and\\ thickening\\ of\\ the\\ nerve\\ roots\\ of\\ the\\ cauda\\ equina\\ with\\ increased\\ meningeal\\ enhancement\\ about\\ the\\ conus\\ medullaris\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ partially\\ visualized\\ sacroiliac\\ joints\\ are\\ unremarkable\\.\\ \\ paraspinal\\ soft\\ \ \(0\)\
\-\ tissues\\ are\\ unremarkable\\.\ \(11\)\
\-\ \\ \ \(1082074\)\
\-\ impression\\:\\ \\ \ \(0\)\
\-\ interval\\ worsening\\ of\\ diffuse\\ leptomeningeal\\ enhancement\\ around\\ the\\ conus\\ \ \(0\)\
\-\ medullaris\\ and\\ cauda\\ equina\\ \\(thickened\\)\\,\\ compatible\\ with\\ progression\\ of\\ \ \(1\)\
\-\ neurosarcoidosis\\.\ \(1\)\
\-\ spinal\\ leptomeningeal\\ neurosarcoidosis\\ of\\ the\\ conus\\ medullaris\ \(0\)\
\-\ 1\\.\\ neurosarcoidosis\ \(0\)\
\-\ 2\\.\\ tuberculous\\ meningitis\ \(0\)\
\-\ 3\\.\\ leptomenigeal\\ carcinomatosis\ \(0\)\
\-\ 4\\.\\ chronic\\ inflammatory\\ demyelinating\\ polyneuropathy\ \(0\)\
\-\ 5\\.\\ lymphoma\ \(0\)\
\-\ 54\\ yo\\ lhd\\ woman\\ presents\\ with\\ progressively\\ increasing\\ weakness\\ of\\ her\\ bilateral\\ lower\\ extremities\\ l\\>r\\.\\ her\\ neurologic\\ symptoms\\ began\\ in\\ 2009\\.\\ she\\ noticed\\ that\\ she\\ was\\ tripping\\ and\\ falling\\ frequently\\,\\ and\\ it\\ felt\\ as\\ if\\ she\\ was\\ not\\ lifting\\ her\\ legs\\ up\\ high\\ enough\\.\\ in\\ march\\ 2009\\,\\ she\\ had\\ an\\ mri\\ due\\ to\\ chronic\\ lower\\ back\\ pain\\,\\ at\\ that\\ time\\ an\\ intramedullary\\ lesion\\ at\\ l1\\ and\\ and\\ extramedullary\\ lesion\\ at\\ the\\ conus\\ medullaris\\ were\\ noted\\.\\ \ \(0\)\
\-\ other\\ symptoms\\ included\\ cough\\ and\\ shortness\\ of\\ breath\\.\\ she\\ was\\ subsequently\\ diagnosed\\ with\\ sarcoidosis\\ by\\ mediastinal\\ lymph\\ node\\ biopsy\\ in\\ 2009\\.\\ she\\ was\\ placed\\ on\\ oral\\ prednisone\\ for\\ 7\\ months\\ with\\ minimal\\ relief\\ of\\ symptoms\\.\\ in\\ 2011\\,\\ she\\ had\\ a\\ steroid\\ infusion\\ followed\\ by\\ methotrexate\\ maintenance\\ which\\ she\\ says\\ helped\\ her\\ symptoms\\ for\\ several\\ months\\.\\ her\\ most\\ recent\\ infusion\\ was\\ in\\ 2014\\,\\ but\\ she\\ only\\ had\\ a\\ 4\\ week\\ improvement\\ of\\ symptoms\\.\\ \\ \ \(0\)\
\-\ over\\ the\\ past\\ 2\\ months\\,\\ the\\ patient\\ notes\\ progressive\\ weakness\\.\\ her\\ left\\ leg\\ is\\ more\\ affected\\ than\\ her\\ right\\ leg\\.\\ pt\\ began\\ falling\\ frequently\\ and\\ is\\ no\\ longer\\ able\\ to\\ ambulate\\ without\\ assistance\\,\\ she\\ now\\ uses\\ a\\ wheelchair\\.\\ the\\ patient\\ also\\ notes\\ decreased\\ sensation\\ in\\ both\\ feet\\ as\\ well\\ as\\ decreased\\ sensation\\ in\\ both\\ lateral\\ legs\\.\\ the\\ patient\\ also\\ has\\ neuropathic\\ pain\\ in\\ the\\ legs\\ for\\ which\\ she\\ takes\\ neurontin\\.\\ she\\ reports\\ occasional\\ urge\\ sensations\\ in\\ her\\ bladder\\,\\ but\\ denies\\ incontinence\\ of\\ bladder\\ or\\ bowel\\.\\ at\\ times\\ she\\ does\\ experience\\ urinary\\ retention\\.\\ pt\\ also\\ endorses\\ difficulty\\ with\\ writing\\,\\ with\\ her\\ hands\\ \\"more\\ shaky\\"\\ than\\ usual\\ over\\ these\\ past\\ 2\\ months\\.\\ she\\ also\\ has\\ once\\ weekly\\ headaches\\,\\ but\\ denies\\ any\\ associated\\ neurologic\\ symptoms\\.\ \(0\)\
\-\ neurologic\\ complications\\ of\\ sarcoidosis\\ occur\\ in\\ 5\\ to\\ 10\\ percent\\ of\\ patients\\ with\\ sarcoidosis\\.\\ it\\ was\\ helpful\\ in\\ this\\ case\\ that\\ the\\ patient\\ previously\\ carried\\ this\\ diagnosis\\.\\ any\\ portion\\ of\\ the\\ peripheral\\ or\\ central\\ nervous\\ system\\ can\\ be\\ affected\\ by\\ sarcoidosis\\.\\ it\\ is\\ important\\ in\\ patients\\ who\\ present\\ with\\ this\\ to\\ have\\ a\\ full\\ evaluation\\ to\\ rule\\-out\\ infectious\\ or\\ malignant\\ causes\\.\\ the\\ gold\\ standard\\ for\\ diagnosis\\ of\\ sarcoidosis\\ is\\ biopsy\\.\\ extraneural\\ tissue\\ biopsy\\ is\\ preferred\\ if\\ other\\ organ\\ systems\\ are\\ involved\\.\\ corticosteroids\\ are\\ the\\ first\\ line\\ treatment\\ in\\ these\\ patients\\,\\ however\\ other\\ immunomodulating\\ therapies\\ may\\ be\\ considered\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ she\\:\\ 0\\.03670273877634799\ \(0\)\
\-\ \\:\\:\\ 0\\.03458764464233729\ \(0\)\
\-\ medullaris\\:\\ 0\\.03153549719258511\ \(0\)\
\-\ flexion\\:\\ 0\\.03008635574826327\ \(0\)\
\-\ neurosarcoidosis\\:\\ 0\\.028903339094972124\ \(0\)\
\-\ 0\\/4\\:\\ 0\\.02847183969824023\ \(0\)\
\-\ conus\\:\\ 0\\.028152769277797005\ \(0\)\
\-\ her\\:\\ 0\\.02527290155886822\ \(0\)\
\-\ triceps\\:\\ 0\\.021800555311376625\ \(0\)\
\-\ biceps\\:\\ 0\\.021099603835638137\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.021091209652269058\ \(0\)\
\-\ legs\\:\\ 0\\.02022235489372709\ \(0\)\
\-\ 3\\/5\\:\\ 0\\.019812884267956448\ \(0\)\
\-\ 1\\/4\\:\\ 0\\.019812884267956448\ \(0\)\
\-\ ab\\/adduction\\:\\ 0\\.01926889272998142\ \(0\)\
\-\ \\,\\:\\ 0\\.018934911686455072\ \(0\)\
\-\ interossei\\:\\ 0\\.017753816925478803\ \(0\)\
\-\ disc\\:\\ 0\\.017395569473289706\ \(0\)\
\-\ wrist\\:\\ 0\\.017258946332288156\ \(0\)\
\-\ sensation\\:\\ 0\\.0171592100360426\ \(0\)\
\-\ 2\\/4\\:\\ 0\\.01715409667380455\ \(0\)\
\-\ fasciculations\\:\\ 0\\.016238741120976192\ \(0\)\
\-\ neurologic\\:\\ 0\\.015599975308441583\ \(0\)\
\-\ 5\\/5\\:\\ 0\\.015590411191541243\ \(0\)\
\-\ plantarflexion\\:\\ 0\\.015352478589592225\ \(0\)\
\-\ 2009\\.\\:\\ 0\\.015352478589592225\ \(0\)\
\-\ hip\\:\\ 0\\.014880316380815118\ \(0\)\
\-\ finger\\:\\ 0\\.014836258960059369\ \(0\)\
\-\ symptoms\\:\\ 0\\.013964967061627141\ \(0\)\
\-\ dorsiflexion\\:\\ 0\\.013662446047005379\ \(0\)\
\-\ maintenance\\:\\ 0\\.01350046140841801\ \(0\)\
\-\ br\\:\\ 0\\.013349657317736149\ \(0\)\
\-\ tremor\\:\\ 0\\.013076076677399524\ \(0\)\
\-\ symmetric\\:\\ 0\\.01279627389583753\ \(0\)\
\-\ l\\:\\ 0\\.012772254092256961\ \(0\)\
\-\ r\\:\\ 0\\.012724736035527234\ \(0\)\
\-\ cauda\\:\\ 0\\.012512515782750125\ \(0\)\
\-\ equina\\:\\ 0\\.012512515782750125\ \(0\)\
\-\ notes\\:\\ 0\\.012322326980586999\ \(0\)\
\-\ indistinct\\:\\ 0\\.012233098577264038\ \(0\)\
\-\ deltoid\\:\\ 0\\.012233098577264038\ \(0\)\
\-\ infusion\\:\\ 0\\.012233098577264038\ \(0\)\
\-\ lumbar\\:\\ 0\\.011913884831719387\ \(0\)\
\-\ l2\\:\\ 0\\.011626253251366158\ \(0\)\
\-\ decreased\\:\\ 0\\.011107131815189332\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.011099123072531431\ \(0\)\
\-\ extremities\\:\\ 0\\.010989136455543896\ \(0\)\
\-\ l5\\-s1\\:\\ 0\\.010900277655688313\ \(0\)\
\-\ plantar\\:\\ 0\\.010674738341512944\ \(0\)\
\-\ temperature\\:\\ 0\\.010549801917819068\ \(0\)\
\-\ falling\\:\\ 0\\.010549801917819068\ \(0\)\
\-\ weakness\\:\\ 0\\.010405283124683229\ \(0\)\
\-\ intact\\:\\ 0\\.01029103154655153\ \(0\)\
\-\ months\\:\\ 0\\.010203022053289912\ \(0\)\
\-\ knee\\:\\ 0\\.010158985975607463\ \(0\)\
\-\ touch\\:\\ 0\\.010078307769564006\ \(0\)\
\-\ achilles\\:\\ 0\\.010045925068394298\ \(0\)\
\-\ extension\\:\\ 0\\.010001073184202142\ \(0\)\
\-\ biopsy\\:\\ 0\\.009939977841432001\ \(0\)\
\-\ patellar\\:\\ 0\\.009920988644700422\ \(0\)\
\-\ hands\\:\\ 0\\.009663539386435101\ \(0\)\
\-\ hypometric\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ gaze\\-evoked\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ momi\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ lt\\/pp\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ v1\\/v2\\/v3\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ volitional\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ palate\\/uvula\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ finger\\-nose\\-finger\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ tapping\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ end\\-point\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ heel\\-shin\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ 5\\/14\\/2015\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ non\\-rib\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ lhd\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ urge\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ shaky\\:\\ 0\\.00963444636499071\ \(0\)\
\-\ feet\\:\\ 0\\.009558179601040833\ \(0\)\
\-\ began\\:\\ 0\\.009457665692315539\ \(0\)\
\-\ \\>\\:\\ 0\\.009308745949732997\ \(0\)\
\-\ unremarkable\\:\\ 0\\.009275627602236264\ \(0\)\
\-\ are\\:\\ 0\\.008911603396401326\ \(0\)\
\-\ hypophonia\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ dysphonia\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ leptomenigeal\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ neurontin\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ extraneural\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ immunomodulating\\:\\ 0\\.008876908462739402\ \(0\)\
\-\ at\\:\\ 0\\.008857204447892274\ \(0\)\
\-\ light\\:\\ 0\\.008715201500905349\ \(0\)\
\-\ margins\\:\\ 0\\.008483157357018156\ \(0\)\
\-\ no\\:\\ 0\\.008463385088889856\ \(0\)\
\-\ vfftc\\:\\ 0\\.008433777197047418\ \(0\)\
\-\ pursuits\\:\\ 0\\.008433777197047418\ \(0\)\
\-\ upper\\/lower\\:\\ 0\\.008433777197047418\ \(0\)\
\-\ xi\\:\\ 0\\.008433777197047418\ \(0\)\
\-\ vibratory\\:\\ 0\\.008433777197047418\ \(0\)\
\-\ in\\:\\ 0\\.008289781576529607\ \(0\)\
\-\ saccades\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ conversation\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ ix\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ scm\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ vibration\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ infliximab\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ dated\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ tripping\\:\\ 0\\.008119370560488096\ \(0\)\
\-\ frequently\\:\\ 0\\.008095148930294983\ \(0\)\
\-\ affected\\:\\ 0\\.008082021008851898\ \(0\)\
\-\ denies\\:\\ 0\\.007882037751093066\ \(0\)\
\-\ lue\\:\\ 0\\.007875497826811365\ \(0\)\
\-\ flexion\\/extension\\:\\ 0\\.0076762392947961125\ \(0\)\
\-\ carried\\:\\ 0\\.0076762392947961125\ \(0\)\
\-\ bladder\\:\\ 0\\.007581225996172742\ \(0\)\
\-\ up\\:\\ 0\\.007533925085423683\ \(0\)\
\-\ enhancement\\:\\ 0\\.0075097992331902815\ \(0\)\
\-\ xii\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ bulk\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ rue\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ deferred\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ wheelchair\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ sensations\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ rule\\-out\\:\\ 0\\.007507768606460311\ \(0\)\
\-\ vertebral\\:\\ 0\\.00739190474407051\ \(0\)\
\-\ also\\:\\ 0\\.007364457240088093\ \(0\)\
\-\ induction\\:\\ 0\\.007361832658236789\ \(0\)\
\-\ heights\\:\\ 0\\.007361832658236789\ \(0\)\
\-\ writing\\:\\ 0\\.007361832658236789\ \(0\)\
\-\ leg\\:\\ 0\\.0073446935707296105\ \(0\)\
\-\ normal\\:\\ 0\\.007320286637153558\ \(0\)\
\-\ patients\\:\\ 0\\.007251064260216478\ \(0\)\
\-\ rle\\:\\ 0\\.007233108029104129\ \(0\)\
\-\ terminates\\:\\ 0\\.007233108029104129\ \(0\)\
\-\ expression\\:\\ 0\\.007117959924560057\ \(0\)\
\-\ viii\\:\\ 0\\.007117959924560057\ \(0\)\
\-\ pronator\\:\\ 0\\.007117959924560057\ \(0\)\
\-\ trapezius\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ drift\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ lle\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ \\-left\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ desiccation\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ assistance\\:\\ 0\\.007013795793626369\ \(0\)\
\-\ pt\\:\\ 0\\.00694462022870547\ \(0\)\
\-\ 2\\/5\\:\\ 0\\.006918701392544806\ \(0\)\
\-\ endorses\\:\\ 0\\.006918701392544806\ \(0\)\
\-\ vi\\:\\ 0\\.006831223023502689\ \(0\)\
\-\ \\-right\\:\\ 0\\.006831223023502689\ \(0\)\
\-\ bilateral\\:\\ 0\\.006799402391194898\ \(0\)\
\-\ says\\:\\ 0\\.006750230704209005\ \(0\)\
\-\ spinal\\:\\ 0\\.006688035432523685\ \(0\)\
\-\ ambulate\\:\\ 0\\.0066748286588680745\ \(0\)\
\-\ perrl\\:\\ 0\\.006604294755985483\ \(0\)\
\-\ vii\\:\\ 0\\.006604294755985483\ \(0\)\
\-\ helped\\:\\ 0\\.006604294755985483\ \(0\)\
\-\ weekly\\:\\ 0\\.006604294755985483\ \(0\)\
\-\ or\\:\\ 0\\.006567362288286607\ \(0\)\
\-\ tuberculous\\:\\ 0\\.006538038338699762\ \(0\)\
\-\ l1\\:\\ 0\\.006538038338699762\ \(0\)\
\-\ was\\:\\ 0\\.006480508342384832\ \(0\)\
\-\ od\\:\\ 0\\.006475570126852824\ \(0\)\
\-\ dysarthria\\:\\ 0\\.006475570126852824\ \(0\)\
\-\ coordination\\:\\ 0\\.006475570126852824\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.006475570126852824\ \(0\)\
\-\ uses\\:\\ 0\\.006475570126852824\ \(0\)\
\-\ other\\:\\ 0\\.006457831307221143\ \(0\)\
\-\ mri\\:\\ 0\\.006436970016113507\ \(0\)\
\-\ endplate\\:\\ 0\\.006416480267541047\ \(0\)\
\-\ 2014\\:\\ 0\\.006416480267541047\ \(0\)\
\-\ extramedullary\\:\\ 0\\.006307099438517021\ \(0\)\
\-\ lower\\:\\ 0\\.006301187112668402\ \(0\)\
\-\ it\\:\\ 0\\.006297863555845956\ \(0\)\
\-\ hoarseness\\:\\ 0\\.006256257891375063\ \(0\)\
\-\ sacroiliac\\:\\ 0\\.006256257891375063\ \(0\)\
\-\ neuropathic\\:\\ 0\\.006256257891375063\ \(0\)\
\-\ retention\\:\\ 0\\.006256257891375063\ \(0\)\
\-\ therapies\\:\\ 0\\.006256257891375063\ \(0\)\
\-\ nervous\\:\\ 0\\.006207676730095463\ \(0\)\
\-\ gold\\:\\ 0\\.006161163490293499\ \(0\)\
\-\ spine\\:\\ 0\\.006151046002197481\ \(0\)\
\-\ had\\:\\ 0\\.006045409243412158\ \(0\)\
\-\ person\\:\\ 0\\.006032438861160841\ \(0\)\
\-\ rise\\:\\ 0\\.006032438861160841\ \(0\)\
\-\ march\\:\\ 0\\.006032438861160841\ \(0\)\
\-\ but\\:\\ 0\\.005975420659126353\ \(0\)\
\-\ meningeal\\:\\ 0\\.005954341632765053\ \(0\)\
\-\ lifting\\:\\ 0\\.005954341632765053\ \(0\)\
\-\ 2009\\:\\ 0\\.005954341632765053\ \(0\)\
\-\ methotrexate\\:\\ 0\\.005954341632765053\ \(0\)\
\-\ past\\:\\ 0\\.0059348622337626975\ \(0\)\
\-\ 2011\\:\\ 0\\.005917290756616768\ \(0\)\
\-\ any\\:\\ 0\\.005881606629666216\ \(0\)\
\-\ nystagmus\\:\\ 0\\.005881454884679073\ \(0\)\
\-\ maintained\\:\\ 0\\.005846756853734176\ \(0\)\
\-\ demyelinating\\:\\ 0\\.0057805004364484555\ \(0\)\
\-\ intramedullary\\:\\ 0\\.0057805004364484555\ \(0\)\
\-\ eomi\\:\\ 0\\.005748820068280967\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.005718032224601518\ \(0\)\
\-\ takes\\:\\ 0\\.005718032224601518\ \(0\)\
\-\ horizontal\\:\\ 0\\.005688087990516146\ \(0\)\
\-\ tongue\\:\\ 0\\.005688087990516146\ \(0\)\
\-\ alignment\\:\\ 0\\.005688087990516146\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.005688087990516146\ \(0\)\
\-\ as\\:\\ 0\\.005650612047624602\ \(0\)\
\-\ os\\:\\ 0\\.005575897658210044\ \(0\)\
\-\ enough\\:\\ 0\\.005575897658210044\ \(0\)\
\-\ roots\\:\\ 0\\.005549561536265716\ \(0\)\
\-\ preferred\\:\\ 0\\.005549561536265716\ \(0\)\
\-\ prednisone\\:\\ 0\\.005523845145653482\ \(0\)\
\-\ incontinence\\:\\ 0\\.005523845145653482\ \(0\)\
\-\ foraminal\\:\\ 0\\.005498719989123756\ \(0\)\
\-\ vertical\\:\\ 0\\.005474159490924785\ \(0\)\
\-\ organ\\:\\ 0\\.005474159490924785\ \(0\)\
\-\ 5\\:\\ 0\\.005464831524468116\ \(0\)\
\-\ usual\\:\\ 0\\.005450138827844156\ \(0\)\
\-\ 4\\/5\\:\\ 0\\.005403625588042194\ \(0\)\
\-\ bearing\\:\\ 0\\.005403625588042194\ \(0\)\
\-\ protrusion\\:\\ 0\\.0053810908479299145\ \(0\)\
\-\ time\\:\\ 0\\.005275631097790847\ \(0\)\
\-\ longer\\:\\ 0\\.005274900958909534\ \(0\)\
\-\ chronic\\:\\ 0\\.005261179525479782\ \(0\)\
\-\ tone\\:\\ 0\\.005235154899706392\ \(0\)\
\-\ compatible\\:\\ 0\\.005159752854365462\ \(0\)\
\-\ v\\:\\ 0\\.005123916982427767\ \(0\)\
\-\ experience\\:\\ 0\\.005123916982427767\ \(0\)\
\-\ noticed\\:\\ 0\\.005106430270573733\ \(0\)\
\-\ percent\\:\\ 0\\.0050892189514828694\ \(0\)\
\-\ if\\:\\ 0\\.005068291658536908\ \(0\)\
\-\ progressively\\:\\ 0\\.005022962534197149\ \(0\)\
\-\ paraspinal\\:\\ 0\\.00499128216602966\ \(0\)\
\-\ impression\\:\\ 0\\.00499128216602966\ \(0\)\
\-\ due\\:\\ 0\\.00498421235618107\ \(0\)\
\-\ systems\\:\\ 0\\.004960494322350211\ \(0\)\
\-\ 54\\:\\ 0\\.00493055008826484\ \(0\)\
\-\ steroid\\:\\ 0\\.00493055008826484\ \(0\)\
\-\ occasional\\:\\ 0\\.00493055008826484\ \(0\)\
\-\ mild\\:\\ 0\\.004918586784548934\ \(0\)\
\-\ is\\:\\ 0\\.004916203526860989\ \(0\)\
\-\ height\\:\\ 0\\.00491588012068873\ \(0\)\
\-\ than\\:\\ 0\\.004894095857744861\ \(0\)\
\-\ these\\:\\ 0\\.004860862714661946\ \(0\)\
\-\ comparison\\:\\ 0\\.004859093520764456\ \(0\)\
\-\ fatty\\:\\ 0\\.004845346217806138\ \(0\)\
\-\ meningitis\\:\\ 0\\.004845346217806138\ \(0\)\
\-\ that\\:\\ 0\\.0048392810772420435\ \(0\)\
\-\ sensory\\:\\ 0\\.004831769693217551\ \(0\)\
\-\ helpful\\:\\ 0\\.004831769693217551\ \(0\)\
\-\ atrophy\\:\\ 0\\.004818359755958738\ \(0\)\
\-\ s1\\:\\ 0\\.004818359755958738\ \(0\)\
\-\ once\\:\\ 0\\.004779089800520417\ \(0\)\
\-\ standard\\:\\ 0\\.004779089800520417\ \(0\)\
\-\ both\\:\\ 0\\.004769836045215566\ \(0\)\
\-\ relief\\:\\ 0\\.004766307243402175\ \(0\)\
\-\ over\\:\\ 0\\.0047555029292676776\ \(0\)\
\-\ nerves\\:\\ 0\\.004741182086872449\ \(0\)\
\-\ neural\\:\\ 0\\.004728832846157769\ \(0\)\
\-\ more\\:\\ 0\\.0046714236269118385\ \(0\)\
\-\ to\\:\\ 0\\.004667411021234823\ \(0\)\
\-\ by\\:\\ 0\\.004665150502442213\ \(0\)\
\-\ alert\\:\\ 0\\.0046575317293617025\ \(0\)\
\-\ progression\\:\\ 0\\.004646087685790888\ \(0\)\
\-\ hearing\\:\\ 0\\.004601473484129406\ \(0\)\
\-\ oriented\\:\\ 0\\.0045798312685051655\ \(0\)\
\-\ interval\\:\\ 0\\.0045798312685051655\ \(0\)\
\-\ increased\\:\\ 0\\.004569365643277936\ \(0\)\
\-\ place\\:\\ 0\\.004537791617327248\ \(0\)\
\-\ times\\:\\ 0\\.004527529606015947\ \(0\)\
\-\ again\\:\\ 0\\.004487418822572857\ \(0\)\
\-\ noted\\:\\ 0\\.004427150138694194\ \(0\)\
\-\ reflexes\\:\\ 0\\.004420583387432605\ \(0\)\
\-\ able\\:\\ 0\\.0044022149521141555\ \(0\)\
\-\ without\\:\\ 0\\.004397842986575214\ \(0\)\
\-\ felt\\:\\ 0\\.004393145222262029\ \(0\)\
\-\ iii\\:\\ 0\\.0043841501412385155\ \(0\)\
\-\ bodies\\:\\ 0\\.004375228490266754\ \(0\)\
\-\ mental\\:\\ 0\\.0043576007504526745\ \(0\)\
\-\ improvement\\:\\ 0\\.0043576007504526745\ \(0\)\
\-\ gait\\:\\ 0\\.004348892368322426\ \(0\)\
\-\ urinary\\:\\ 0\\.004323175977710193\ \(0\)\
\-\ included\\:\\ 0\\.0043063618587599415\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004289004001705836\ \(0\)\
\-\ partially\\:\\ 0\\.004273490322981496\ \(0\)\
\-\ joints\\:\\ 0\\.004273490322981496\ \(0\)\
\-\ node\\:\\ 0\\.004273490322981496\ \(0\)\
\-\ muscles\\:\\ 0\\.004265424631945843\ \(0\)\
\-\ degenerative\\:\\ 0\\.004233744263778354\ \(0\)\
\-\ subsequently\\:\\ 0\\.004233744263778354\ \(0\)\
\-\ this\\:\\ 0\\.004201692735799489\ \(0\)\
\-\ important\\:\\ 0\\.004195393094585709\ \(0\)\
\-\ thickened\\:\\ 0\\.004187881751101816\ \(0\)\
\-\ difficulty\\:\\ 0\\.004158342218437423\ \(0\)\
\-\ strength\\:\\ 0\\.004143866560787128\ \(0\)\
\-\ marrow\\:\\ 0\\.004108494665156492\ \(0\)\
\-\ smooth\\:\\ 0\\.004087808315554832\ \(0\)\
\-\ case\\:\\ 0\\.004086348487141575\ \(0\)\
\-\ cranial\\:\\ 0\\.004060821853707431\ \(0\)\
\-\ facial\\:\\ 0\\.004060821853707431\ \(0\)\
\-\ full\\:\\ 0\\.004034485731763103\ \(0\)\
\-\ ii\\:\\ 0\\.004027999682014672\ \(0\)\
\-\ 5\\.\\:\\ 0\\.004027999682014672\ \(0\)\
\-\ 2\\:\\ 0\\.004022086331170593\ \(0\)\
\-\ infectious\\:\\ 0\\.004015141931654468\ \(0\)\
\-\ mildly\\:\\ 0\\.003977452121740622\ \(0\)\
\-\ mediastinal\\:\\ 0\\.003965172260246713\ \(0\)\
\-\ oral\\:\\ 0\\.003935063023341544\ \(0\)\
\-\ shortness\\:\\ 0\\.003929139452336802\ \(0\)\
\-\ previously\\:\\ 0\\.003923247814484478\ \(0\)\
\-\ involved\\:\\ 0\\.003917387767335422\ \(0\)\
\-\ motor\\:\\ 0\\.003899993827110396\ \(0\)\
\-\ around\\:\\ 0\\.003888549783539581\ \(0\)\
\-\ limits\\:\\ 0\\.0038494137696633945\ \(0\)\
\-\ line\\:\\ 0\\.003838484716838713\ \(0\)\
\-\ tissues\\:\\ 0\\.0038330609033500472\ \(0\)\
\-\ increasing\\:\\ 0\\.0038276638742346567\ \(0\)\
\-\ lesion\\:\\ 0\\.0038044922972687535\ \(0\)\
\-\ visualized\\:\\ 0\\.0037802537150759406\ \(0\)\
\-\ placed\\:\\ 0\\.0037802537150759406\ \(0\)\
\-\ lymph\\:\\ 0\\.003769991703764641\ \(0\)\
\-\ considered\\:\\ 0\\.003769991703764641\ \(0\)\
\-\ reports\\:\\ 0\\.003764896607474137\ \(0\)\
\-\ narrowing\\:\\ 0\\.0037447504854098332\ \(0\)\
\-\ patient\\:\\ 0\\.0037446641788694557\ \(0\)\
\-\ partial\\:\\ 0\\.0037348149972117437\ \(0\)\
\-\ canal\\:\\ 0\\.0037103643985729093\ \(0\)\
\-\ complications\\:\\ 0\\.0037007352950951446\ \(0\)\
\-\ progressive\\:\\ 0\\.0036911902896648117\ \(0\)\
\-\ worsening\\:\\ 0\\.0036770272900555167\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0036770272900555167\ \(0\)\
\-\ minimal\\:\\ 0\\.0036770272900555167\ \(0\)\
\-\ system\\:\\ 0\\.0036770272900555167\ \(0\)\
\-\ causes\\:\\ 0\\.003635607320010723\ \(0\)\
\-\ midline\\:\\ 0\\.003613256926053028\ \(0\)\
\-\ about\\:\\ 0\\.0036000628482013683\ \(0\)\
\-\ cough\\:\\ 0\\.003578420632577128\ \(0\)\
\-\ 7\\:\\ 0\\.003578420632577128\ \(0\)\
\-\ headaches\\:\\ 0\\.0035698823377828177\ \(0\)\
\-\ and\\:\\ 0\\.0035411607685026584\ \(0\)\
\-\ has\\:\\ 0\\.0035075409191131757\ \(0\)\
\-\ occur\\:\\ 0\\.0035038760970290037\ \(0\)\
\-\ breath\\:\\ 0\\.003491931757649561\ \(0\)\
\-\ which\\:\\ 0\\.003486654835502839\ \(0\)\
\-\ diagnosed\\:\\ 0\\.003434093067535525\ \(0\)\
\-\ iv\\:\\ 0\\.003408114685749829\ \(0\)\
\-\ portion\\:\\ 0\\.003382739505310477\ \(0\)\
\-\ peripheral\\:\\ 0\\.0033791621005618768\ \(0\)\
\-\ malignant\\:\\ 0\\.003375596367627651\ \(0\)\
\-\ nerve\\:\\ 0\\.003364968444248422\ \(0\)\
\-\ otherwise\\:\\ 0\\.003354442878061579\ \(0\)\
\-\ status\\:\\ 0\\.003333691061400714\ \(0\)\
\-\ location\\:\\ 0\\.0032576040294031616\ \(0\)\
\-\ labs\\:\\ 0\\.0032480590239728287\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0032385966603191516\ \(0\)\
\-\ 3\\.\\:\\ 0\\.003195490942230303\ \(0\)\
\-\ now\\:\\ 0\\.0031924760543187406\ \(0\)\
\-\ for\\:\\ 0\\.0031873580268533992\ \(0\)\
\-\ does\\:\\ 0\\.0031864711151737774\ \(0\)\
\-\ the\\:\\ 0\\.0031729344030340346\ \(0\)\
\-\ week\\:\\ 0\\.003171601550085495\ \(0\)\
\-\ thickening\\:\\ 0\\.0031657099122331714\ \(0\)\
\-\ type\\:\\ 0\\.003148223200379137\ \(0\)\
\-\ 10\\:\\ 0\\.003148223200379137\ \(0\)\
\-\ recent\\:\\ 0\\.0031395836599342045\ \(0\)\
\-\ first\\:\\ 0\\.0031338616773615873\ \(0\)\
\-\ followed\\:\\ 0\\.003131011881288275\ \(0\)\
\-\ x\\:\\ 0\\.003080946814587407\ \(0\)\
\-\ back\\:\\ 0\\.003080946814587407\ \(0\)\
\-\ central\\:\\ 0\\.0030728211550382066\ \(0\)\
\-\ body\\:\\ 0\\.003033075095835065\ \(0\)\
\-\ several\\:\\ 0\\.0030022872521556147\ \(0\)\
\-\ medial\\:\\ 0\\.0029872125831585266\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0029698843079784243\ \(0\)\
\-\ bowel\\:\\ 0\\.002928910964901376\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0029171466298334434\ \(0\)\
\-\ be\\:\\ 0\\.002880342564686184\ \(0\)\
\-\ diffuse\\:\\ 0\\.0028273305140713825\ \(0\)\
\-\ yo\\:\\ 0\\.002810220244046734\ \(0\)\
\-\ only\\:\\ 0\\.00280810017320758\ \(0\)\
\-\ there\\:\\ 0\\.002779706134349702\ \(0\)\
\-\ primary\\:\\ 0\\.0027665401780280837\ \(0\)\
\-\ evaluation\\:\\ 0\\.0027128292850566206\ \(0\)\
\-\ loss\\:\\ 0\\.002710889805976437\ \(0\)\
\-\ level\\:\\ 0\\.002691681997428341\ \(0\)\
\-\ changes\\:\\ 0\\.002676555165284219\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0026690695457808585\ \(0\)\
\-\ 4\\:\\ 0\\.002602155087627372\ \(0\)\
\-\ however\\:\\ 0\\.0026004022465541754\ \(0\)\
\-\ an\\:\\ 0\\.0025828740202944915\ \(0\)\
\-\ high\\:\\ 0\\.002555788044892695\ \(0\)\
\-\ significant\\:\\ 0\\.0025113083618078943\ \(0\)\
\-\ therapy\\:\\ 0\\.002496875187148211\ \(0\)\
\-\ signal\\:\\ 0\\.0024623763172380094\ \(0\)\
\-\ who\\:\\ 0\\.002434938152067434\ \(0\)\
\-\ bone\\:\\ 0\\.0023206936409397487\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0022952295493243904\ \(0\)\
\-\ pain\\:\\ 0\\.0022811107487010593\ \(0\)\
\-\ soft\\:\\ 0\\.002274236900539399\ \(0\)\
\-\ upper\\:\\ 0\\.002253639896577834\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.002251092351893162\ \(0\)\
\-\ tissue\\:\\ 0\\.002213575069347097\ \(0\)\
\-\ associated\\:\\ 0\\.002203784220664155\ \(0\)\
\-\ a\\:\\ 0\\.0021672120317956355\ \(0\)\
\-\ of\\:\\ 0\\.0021645514902358504\ \(0\)\
\-\ woman\\:\\ 0\\.0021572709808621924\ \(0\)\
\-\ most\\:\\ 0\\.002156103980030684\ \(0\)\
\-\ were\\:\\ 0\\.0021205315155081107\ \(0\)\
\-\ can\\:\\ 0\\.0021182757950481633\ \(0\)\
\-\ well\\:\\ 0\\.0021126567792007114\ \(0\)\
\-\ present\\:\\ 0\\.002109299184624788\ \(0\)\
\-\ contrast\\:\\ 0\\.0020904652314840495\ \(0\)\
\-\ exam\\:\\ 0\\.002051621792294577\ \(0\)\
\-\ may\\:\\ 0\\.0020484463048066927\ \(0\)\
\-\ have\\:\\ 0\\.002022336697666767\ \(0\)\
\-\ lateral\\:\\ 0\\.0020182164433055197\ \(0\)\
\-\ findings\\:\\ 0\\.0019877999298250925\ \(0\)\
\-\ presents\\:\\ 0\\.0019078079732327059\ \(0\)\
\-\ \\.\\:\\ 0\\.001901068053300511\ \(0\)\
\-\ treatment\\:\\ 0\\.0018902917591266525\ \(0\)\
\-\ seen\\:\\ 0\\.001845494661276164\ \(0\)\
\-\ within\\:\\ 0\\.001781564380749816\ \(0\)\
\-\ on\\:\\ 0\\.0015822754368643238\ \(0\)\
\-\ with\\:\\ 0\\.0015344809979001932\ \(0\)\
\-\ from\\:\\ 0\\.0013840827466166255\ \(0\)\
\-\ not\\:\\ 0\\.0013495286029966507\ \(0\)\
\-\ left\\:\\ 0\\.001044923791555098\ \(0\)\
\-\ right\\:\\ 0\\.0009853898460223133\ \(0\)\
\-\ \\(\\:\\ 0\\.000789466367479629\ \(0\)\
\-\ \\)\\:\\ 0\\.000779822614331481\ \(0\)\
